Test Price
2,800 AED✅ Home Collection Available
FKRP Gene (Muscular Dystrophy Type 1C) NGS Test in UAE | AED 2,800 | DHA Licensed Laboratory
Executive Summary & Core Metrics
UAE Gold‑Standard Genetic Testing Service
- Diagnostic Accuracy: 99.9% clinical sensitivity for single nucleotide variants and small indels via ISO‑accredited next‑generation sequencing.
- Premium Logistics: VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection, available daily from 8 AM to 11 PM.
- Post‑Test Guidance: Telephonic consultation with a DHA‑licensed medical geneticist to integrate results into your care plan.
- Insurance Support: Direct billing verification available via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The FKRP gene test employs clinical‑grade next‑generation sequencing (NGS) to detect pathogenic variants associated with congenital muscular dystrophy‑dystroglycanopathy type A, 1C (MDC1C) and limb‑girdle muscular dystrophy 2I (LGMD2I). This comprehensive molecular approach enables early diagnosis, informed family screening, and targeted treatment planning for patients across the UAE.
| Feature | Our FKRP NGS Test | Closest Alternative |
|---|---|---|
| Method | NGS full gene sequencing | Targeted mutation panel or MLPA |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Clinical Sensitivity | >99.9% for SNVs and indels | 80–90% (novel variants may be missed) |
| Price (AED) | 2,800 | 2,500–3,200 |
Physician Insight & Safety Protocols
“As a DHA‑licensed Consultant Medical Genetics, I recommend this NGS assay for precise molecular diagnosis of FKRP‑related dystroglycanopathies. The result must always be interpreted alongside clinical examination, serum creatine kinase levels, and detailed family history. Genetic findings complement but never replace clinical judgment.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Important Medication Advisory
⚠️ Medication Caution
Do not discontinue any prescribed therapies—including corticosteroids, cardiac medications, or supportive treatments—without consulting your managing physician. Genetic test results are not a substitute for ongoing clinical care and do not alter existing emergency protocols.
Safety Exclusion Criteria & Emergency Red Flags
- Home collection is not available for patients who are medically unstable or lack suitable venous access.
- Patients under legal guardianship must present a valid consent form signed in accordance with UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Seek immediate emergency care for sudden severe muscle weakness, breathing difficulty, or chest pain—do not delay treatment while waiting for genetic results.
- This test is not intended for standalone fetal aneuploidy screening; invasive prenatal testing may still be required in high‑risk pregnancies.
Patient FAQ & Clinical Guidance
1. What conditions does the FKRP gene test detect?
This NGS assay identifies disease‑causing variants in the FKRP gene responsible for congenital muscular dystrophy type 1C (MDC1C) and limb‑girdle muscular dystrophy 2I (LGMD2I). Early molecular diagnosis enables proactive management, including cardiac surveillance, physiotherapy planning, and genetic counselling for at‑risk family members.
2. How is the sample collected and when will results be ready?
A certified phlebotomist collects a peripheral whole blood sample (3–5 mL in an EDTA tube) at your home via our VIP mobile phlebotomy service. Once received in our DHA‑licensed laboratory, the NGS analysis requires 3 to 4 weeks for completion.
3. Will health insurance cover the AED 2,800 cost?
We offer direct billing verification through WhatsApp. Many UAE health insurance plans cover medically necessary genetic testing for muscular dystrophy when ordered by a neurologist or medical geneticist. Contact us to check your eligibility and submit a pre‑authorisation request.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
- All genetic data is processed under Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Patient consent and clinical safety are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- The laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.
- Your genetic information is encrypted, access‑controlled, and used solely for diagnostic purposes. It is never shared with third parties without explicit written consent.
Clinical & Logistical Metadata
| Test Name | FKRP Gene (Muscular Dystrophy Type 1C) NGS Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks (21–28 days) from sample receipt |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) – VIP mobile phlebotomy and temperature‑controlled cold‑chain home collection available daily from 8 AM to 11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene sequencing with >99.9% sensitivity for SNVs and indels |
| ICD-10-CM Code | G71.0 (Muscular dystrophy) |
| LOINC Code | 94268-2 (FKRP gene mutation analysis in blood by sequencing) |
| DHA Facility License & Address | DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians